Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Eve Poret, Fanny Angelot Delettre, Sabeha Biichle, Anne Roogy, Louis Benazet, Maider Pagadoy, Chrystelle Vidal, Franck Leroux, Véronique Harrivel, Christophe Ferrand, PhD, Veronique Salaun, Zehaira Benseddik, Julien Guy, Marie Christine Jacob, Christophe Roumier, Jean Feuillard, Liliana Vila, Lucile Baseggio, Adriana Plesa, Christine Arnoulet, B Benet, Bernard Drenou, MD, Veronique Latger Cannard, Marie-Christine Bene, MD, Michel Ticchioni, Daniel Lusina, Valerie Bardet, Magalie LE Garff Tavernier, Elizabeth Macintyre, MD PhD, Vahid Asnafi, MDPhD, Maria Elena Noguera, Sabrina Bouyer, Carine Lecoq Lafon, Mikael Roussel, MD PhD, Fabrice Jardin, Francoise Solly, MD, Lydia Campos, MD PhD, Anne Galoisy, Anne Arnaud, Sylvie Daliphard, Franck Genevieve, MD PhD, Romaric Lacroix, Françoise Schillinger, Estelle Seilles, Delphine Binda, Eric Deconinck, Philippe Saas, PhD, Francine Garnache Ottou, PhD

Blood (2015) 126 (23): 3812.

https://doi.org/10.1182/blood.V126.23.3812.3812

Published: 2015

Journal Articles

Role Of Allogeneic Transplant In Poor Risk CLL Patients: A Long-Term Monocentric Experience In 39 Patients

Therese Aurran-Schleinitz, MD, Anne Wanquet, Sabine Furst, MD, Benjamin Esterni, Ph.D., Reda Bouabdallah, MD, Diane Coso, MD, Christine Arnoulet, Pharm. D., Jean El Cheikh, MD, Catherine Faucher, MD, Luca Castagna, MD, Christian Chabannon, MD, PhD, Didier Blaise

Blood (2013) 122 (21): 5531.

https://doi.org/10.1182/blood.V122.21.5531.5531

Published: 2013

Journal Articles

Assessment Of Minimal Residual Disease In Acute Myeloblastic Leukemia In Multiparameter Flow Cytometry

Blood (2013) 122 (21): 2613.

https://doi.org/10.1182/blood.V122.21.2613.2613

Published: 2013

Journal Articles

Combination of Cytarabine and Topotecan Improves Response Rate for Patients Treated for Acute Myeloid Leukemia with Persistent Disease After Frontline Induction

Thomas Prebet, MD, PhD, Estelle Jean, M.D., Aurelie Autret, B.Sc., Aude Charbonnier, Jerome Rey, MD, Anne Etienne, MD, Evelyne D'Incan, M.D., Sabine Furst, MD, Christine Arnoulet, Pharm. D., Didier Blaise, MD, Norbert Vey, MD

Blood (2011) 118 (21): 2605.

https://doi.org/10.1182/blood.V118.21.2605.2605

Published: 2011

Journal Articles

Interest of Early Determination of Bone Marrow MRD by a Sensitive 6-Color Flow Cytometry in the Evaluation of Response: The Experience of the CLL2007FMP, An Intergroup Phase III Randomized Multicentric Trial Comparing Fludarabine Cyclophosphamide (FC) and Rituximab (FCR) Versus FC and MabCampath (FCCam) in Previously Untreated B-Chronic Lymphocytic Leukemia Patients

Remi Letestu, MD, Stéphane Leprêtre, MD, Christine Arnoulet, Pharm. D., Lucile Baseggio, Lydia Campos, MD, PhD, Bernard Chatelain, Bernard Drenou, MD, PhD, Marie-Christine Jacob, Eric Legac, Magali Le Garff-Tavernier, Nelly Robillard, Michel Ticchioni, Roselyne Delepine, Vincent Levy, MD, Sandrine Katsahian, Veronique Leblond, Florence Cymbalista, Pr, Pierre Feugier, MD, PhD

Blood (2011) 118 (21): 1797.

https://doi.org/10.1182/blood.V118.21.1797.1797

Published: 2011

Journal Articles

The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome

Thomas Prebet, Anne-Catherine Lhoumeau, Christine Arnoulet, Anaïs Aulas, Sylvie Marchetto, Stéphane Audebert, Francesca Puppo, Christian Chabannon, Danielle Sainty, Marie-Josée Santoni, Michael Sebbagh, Virginia Summerour, Yannick Huon, Won-Sik Shin, Seung-Taek Lee, Benjamin Esterni, Norbert Vey, Jean-Paul Borg

Blood (2010) 116 (13): 2315–2323.

https://doi.org/10.1182/blood-2010-01-262352

Published: 2010

Includes: Supplemental data

Journal Articles

The Cell Polarity PTK7 Receptor Is Expressed in Myeloid Cells and Acts as a Modulator of the Chemotherapeutic Response in AML Patients.

Thomas Prebet, MD, Anne Catherine Lhoumeau, PharmD, Christine Arnoulet, PharmD, Anais Aulas, Sylvie Marchetto, Michael Sebbagh, PhD, Benjamin Esterni, Norbert Vey, Jean Paul Borg, PharmD, PhD

Blood (2009) 114 (22): 1571.

https://doi.org/10.1182/blood.V114.22.1571.1571

Published: 2009

Journal Articles

Expression of the Cell Polarity Protein PTK7 in Acute Myeloid Leukaemia.

Thomas Prebet, MD, Anne Catherine Lhoumeau, PharmD, Christine Arnoulet, PharmD, Sylvie Marchetto, Christian Chabannon, MD, PhD, Danielle Sainty, MD, Norbert Vey, MD, Jean Paul Borg, PharmD, PhD

Blood (2008) 112 (11): 1478.

https://doi.org/10.1182/blood.V112.11.1478.1478

Published: 2008

Journal Articles

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Refractory or Relapsed Non-Hodgkin’s Lymphoma (NHL).

Hugues de Lavallade, MD, Reda Bouabdallah, MD, Catherine Faucher, MD, Sabine Furst, MD, Jean El-Cheikh, MD, Norbert Vey, MD, Anne-Marie Stoppa, MD, Danielle Sainty, MD, Christine Arnoulet, Luc Xerri, MD, Philippe Cassier, MD, Jean-Albert Gastaut, MD, Didier Blaise, MD, Mohamad Mohty, MD, PhD

Blood (2006) 108 (11): 5356.

https://doi.org/10.1182/blood.V108.11.5356.5356

Published: 2006

Journal Articles

Impact of Comorbidities on the Outcome of Elderly Patients with Acute Myeloid Leukemia.

Anne Etienne, Benjamin Esterni, Aude Charbonnier, Thomas Prébet, Diane Coso, Anne-Marie Stoppa, Evelyne D’Incan, Marie-Françoise Doglio, Danièle Sainty, Christine Arnoulet, Marie-Joëlle Mozziconacci, Jean-Albert Gastaut, Norbert Vey

Blood (2006) 108 (11): 1976.

https://doi.org/10.1182/blood.V108.11.1976.1976

Published: 2006

Journal Articles

Assessment of Peripheral Blood (PB) Blast Decrease Rate by Multiparameter Flow Cytometry: A New Prognostic Factor in Acute Myeloblastic Leukaemia (AML). A Goelams Study.

Francis Lacombe, MD, PhD, Christine Arnoulet, MD,PhD, Marc Maynadie, MD,PhD, Arnaud Pigneux, MD,PhD, Norbert Vey, MD, Olivier Casasnovas, MD, Francis Witz, MD, Marie C. Bene, PharmsSciD,PhD

Blood (2006) 108 (11): 1892.

https://doi.org/10.1182/blood.V108.11.1892.1892

Published: 2006

Journal Articles

Familial Malignant Hematological Disorders: A Systematic Assessment in 216 Consecutive Patients with Acute Leukaemia.

Laetitia Huiart, MD, Marina Lafage, MD, Laetitia Rabayrol, MD, Aude Charbonnier, MD, Philippe Bourdeleau, MD, Daniele Sainty, MD, Diane Coso, MD, Marie Joelle Mozziconacci, MD, Christine Arnoulet, MD, Anne-Marie Stoppa, MD, Anne Murati, MD, Marie Pascale Lehucher-Michel, MD, Hagay Sobol, MD, François Esinger, MD, Norbert Vey, MD

Blood (2006) 108 (11): 4500.

https://doi.org/10.1182/blood.V108.11.4500.4500

Published: 2006

Journal Articles

Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCR dull phenotype induction

Cyril Fauriat, Sylvaine Just-Landi, Françoise Mallet, Christine Arnoulet, Danielle Sainty, Daniel Olive, Regis T. Costello

Blood (2006) 109 (1): 323–330.

https://doi.org/10.1182/blood-2005-08-027979

Published: 2006

Journal Articles

Impact of Recovery of CD4 and CD8 Lymphocyte Subsets on Acute GVHD after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT).

Mohamad Mohty, Beatrice Gaugler, Catherine Faucher, Danielle Sainty, Christine Arnoulet, Jean-Albert Gastaut, Patrice Viens, Daniel Olive, Didier Blaise

Blood (2005) 106 (11): 1425.

https://doi.org/10.1182/blood.V106.11.1425.1425

Published: 2005

Journal Articles

FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice

Géraldine Guasch, Bénédicte Delaval, Christine Arnoulet, Min-Jue Xie, Luc Xerri, Danielle Sainty, Daniel Birnbaum, Marie-Josèphe Pébusque

Blood (2004) 103 (1): 309–312.

https://doi.org/10.1182/blood-2003-05-1690

Published: 2004

Journal Articles

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)

Blood (2003) 101 (4): 1277–1283.

https://doi.org/10.1182/blood-2002-05-1474

Published: 2003

Journal Articles

Clinical and biologic features of CD4 + CD56 + malignancies

Blood (2002) 99 (5): 1556–1563.

https://doi.org/10.1182/blood.V99.5.1556

Published: 2002

Journal Articles

A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements

Danielle Sainty, Vincenzo Liso, Angelo Cantù-Rajnoldi, David Head, Marie-Joëlle Mozziconacci, Christine Arnoulet, Laurence Benattar, Susanna Fenu, Marco Mancini, Eliane Duchayne, François-Xavier Mahon, Norma Gutierrez, Françoise Birg, Andrea Biondi, David Grimwade, Marina Lafage-Pochitaloff, Anne Hagemeijer, Georges Flandrin

Blood (2000) 96 (4): 1287–1296.

https://doi.org/10.1182/blood.V96.4.1287

Published: 2000

NARROW

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

Role Of Allogeneic Transplant In Poor Risk CLL Patients: A Long-Term Monocentric Experience In 39 Patients

Assessment Of Minimal Residual Disease In Acute Myeloblastic Leukemia In Multiparameter Flow Cytometry

Combination of Cytarabine and Topotecan Improves Response Rate for Patients Treated for Acute Myeloid Leukemia with Persistent Disease After Frontline Induction

The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome

The Cell Polarity PTK7 Receptor Is Expressed in Myeloid Cells and Acts as a Modulator of the Chemotherapeutic Response in AML Patients.

Expression of the Cell Polarity Protein PTK7 in Acute Myeloid Leukaemia.

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Refractory or Relapsed Non-Hodgkin’s Lymphoma (NHL).

Impact of Comorbidities on the Outcome of Elderly Patients with Acute Myeloid Leukemia.

Assessment of Peripheral Blood (PB) Blast Decrease Rate by Multiparameter Flow Cytometry: A New Prognostic Factor in Acute Myeloblastic Leukaemia (AML). A Goelams Study.

Familial Malignant Hematological Disorders: A Systematic Assessment in 216 Consecutive Patients with Acute Leukaemia.

Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCR dull phenotype induction

Impact of Recovery of CD4 and CD8 Lymphocyte Subsets on Acute GVHD after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT).

FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)

Clinical and biologic features of CD4 + CD56 + malignancies

A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only